| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |